Search research articles
Contact Us
Filters
Showing results (71-80 of 93) with videos related to
Page
of 10
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 1, 2022
Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology
Ansgar W Lohse, Marcial Sebode, Prithi S Bhathal, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
March 17, 2023
Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe
Dominic Lenz, Marianne Hørby Jørgensen, Deirdre Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 25, 2026
6-Mercaptopurine vs. Mycophenolate Mofetil in Autoimmune Hepatitis and Azathioprine Intolerance: A Multicenter Study
Ludwig Jesse Horst, Alexander Fierenz, Bernardo Canhão, et al.
Cell Reports. Medicine
|
June 20, 2024
Intergenic risk variant rs56258221 skews the fate of naive CD4<sup>+</sup> T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
Tobias Poch, Jonas Bahn, Christian Casar, et al.
Journal of Hepatology
|
March 28, 2021
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4<sup>+</sup> T cells in primary sclerosing cholangitis
Tobias Poch, Jenny Krause, Christian Casar, et al.
Frontiers in Immunology
|
February 8, 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Frontiers in Immunology
|
January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Hepatology (Baltimore, Md.)
|
October 22, 2020
Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)
Lilly Kristin Kunzmann, Tanja Schoknecht, Tobias Poch, et al.
Gut
|
October 3, 2023
<i>HLA-DPA1*02:01~B1*01:01</i> is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells
Britta F Zecher, David Ellinghaus, Sebastian Schloer, et al.
JHEP Reports : Innovation in Hepatology
|
November 28, 2022
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
Greta Codoni, Theresa Kirchner, Bastian Engel, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 93) with videos related to
Sort By:
Page
of 10
Liver International : Official Journal of the International Association for the Study of the Liver
|
March 1, 2022
Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology: Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology
Ansgar W Lohse, Marcial Sebode, Prithi S Bhathal, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
March 17, 2023
Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe
Dominic Lenz, Marianne Hørby Jørgensen, Deirdre Kelly, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
January 25, 2026
6-Mercaptopurine vs. Mycophenolate Mofetil in Autoimmune Hepatitis and Azathioprine Intolerance: A Multicenter Study
Ludwig Jesse Horst, Alexander Fierenz, Bernardo Canhão, et al.
Cell Reports. Medicine
|
June 20, 2024
Intergenic risk variant rs56258221 skews the fate of naive CD4<sup>+</sup> T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
Tobias Poch, Jonas Bahn, Christian Casar, et al.
Journal of Hepatology
|
March 28, 2021
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4<sup>+</sup> T cells in primary sclerosing cholangitis
Tobias Poch, Jenny Krause, Christian Casar, et al.
Frontiers in Immunology
|
February 8, 2024
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Frontiers in Immunology
|
January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Hepatology (Baltimore, Md.)
|
October 22, 2020
Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)
Lilly Kristin Kunzmann, Tanja Schoknecht, Tobias Poch, et al.
Gut
|
October 3, 2023
<i>HLA-DPA1*02:01~B1*01:01</i> is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cells
Britta F Zecher, David Ellinghaus, Sebastian Schloer, et al.
JHEP Reports : Innovation in Hepatology
|
November 28, 2022
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination
Greta Codoni, Theresa Kirchner, Bastian Engel, et al.
Page
of 10